34 results about "Subcutaneous fatty tissue" patented technology

Pathological regional adipose tissue accumulation associated with HIV-associated dysmorphic / dysmetabolic syndrome (HADDS) which may occur with or without subcutaneous adipose tissue lipodystrophy (and which is also described as HIV-associated adipose redistribution syndrome or HARS and other specific medical terms), is treated by administering an effective amount of human growth hormone or other substance which binds to and initiates signalling of the hGH receptor. Alternatively, a substance which stimulates production of endogenous hGH, such as human growth hormone releasing hormone, may be administered. HADDS and related syndromes include abnormal adipose tissue accumulation in the visceral, submandibular, supraclavicular, pectoral, mammary and / or dorsocervical (buffalo hump) area, and / or with subcutaneous lipomas, with or without associated metabolic or other physiologic abnormalities.

Exemplary embodiments of method and apparatus are provided for damaging and / or removing portions of subcutaneous fatty tissue while leaving the overlying dermal layer of the skin substantially undamaged. One or more hollow needles can be provided that include an arrangement within the lumen configured to retain or damage portions of fatty tissue that enter the lumen. Properties of the needle can be selected such that the needle can be inserted into skin and pass through the dermal layer, allowing fatty tissue to enter the distal portion of the lumen as it is advanced further, and then leaving the dermis undamaged when withdrawn. Such exemplary apparatus can include a plurality of such needles, a reciprocating arrangement to mechanically advance and withdraw the one or more needles, and / or a vibrating arrangement.

A method and device for stimulating human dermal tissue retraction and collagen and elastin production is provided. One or more lasers or other electromagnetic radiation devices produce at least two output beams (split or independent beams) that can be directed to deliver electromagnetic energy to a desired subsurface depth of dermal tissue, thereby disrupting the same, without causing excessive damage to the adjacent epidermis, subcutaneous fatty tissue, or blood vessels of the skin.

Pharmaceutical preparations for topical or local administration of drugs directly to the skin for treatment of disorders of the subcutaneous fatty tissue, in particular in cases of cellulite, are disclosed herein. In a preferred embodiment, the drug is danazol or gastrinone. In another embodiment, the drug is danazol in combination with an aromatase inhibitor or an estrogen compound. The preferred formulations contain drugs in the form of micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or carrier. The excipient or carrier may modify the release rates or enhance absorption into the affected area. The drug formulation may be in the form of a cream, lotion, ointment, gel or emulsion, solution or foam.

The invention discloses a method for facilitating proliferation of adipose-derived stem cells. The method comprises the following steps: (1) taking a subcutaneous fatty tissue, washing the subcutaneous fatty tissue with a PBS buffer solution, removing an adipose tissue membrane and blood vessels and shearing off the subcutaneous fatty tissue into fragments with the sizes being 1 mm<3>, carrying out enzymic digestion, adding a complete medium after digestion is finished, centrifuging, removing supernatant, resuspending cell precipitates on the complete medium, inoculating the cell precipitatesin a culture bottle, changing a culture solution after culturing for 24 h and removing cells which are not attached to walls, then changing the solution every 3 days, digesting for 3-5 min with 0.25%of trypsin and 1 mmol / L EDTA at the temperature of 37 DEG C after cell fusion, stopping digestion of the complete medium, and carrying out passage at the ratio of 1: 2; and (2) inoculating passage cells into a culture bottle which contains the complete medium at the density of 1.5* 104 / cm<2>, culturing for 48 h and then changing the culture medium into an incomplete medium, meanwhile adding a jatrophane type diterpenoid compound and continuing culturing for 24-72 h. Surface euphorbia helioscopia terpene A, surface euphorbia helioscopia terpene B and surface euphorbia helioscopia terpene F canbe used as an accelerant for proliferation of adipose-derived stem cells, and can be added in a DMEM medium to obtain an adipose-derived stem cell high-proliferation medium.

Provided are: particularly a composition for enlarging the breast, which comprises a composition for promoting the increase in a subcutaneous tissue, wherein the latter composition enables the recovery of an autologous tissue or the recovery of physical appearance through such a safe and natural method that an adipose tissue is formed and increased around a mammary gland to accumulate and increase the adipose tissue under the skin of the breast; and a breast enlargement method. A composition for promoting the increase in a subcutaneous tissue, particularly a composition for enlarging the breast, which is characterized by comprising self-derived plasma and a basic fibroblast proliferation factor (b-FGF); a composition for enlarging the breast, which comprises the above-mentioned composition for promoting the increase in a subcutaneous tissue, wherein the composition additionally comprises a fat, specifically a composition for enlarging the breast which comprises the above-mentioned composition for promoting the increase in a subcutaneous tissue, wherein the fat has the form of a fat emulsion and the fat emulsion has the form of an oil-in-water-type fat emulsion that is produced by emulsifying an oil or fat in the presence of an emulsifying agent; a method for enlarging the breast, in which the composition is used; and a unit for injecting the composition for enlarging the breast.

In particular, a composition for breast augmentation that includes a composition promoting an increase in subcutaneous tissue, wherein the promoting composition aims at accumulating and increasing adipose tissue under the skin of a breast by generating and increasing the adipose tissue around a mammary gland and enables recovery of autologous tissue and recovery of appearance by a safe and natural process, and a method for breast augmentation are provided. A composition promoting an increase in subcutaneous tissue that contains autologous plasma and a basic fibroblast growth factor (b-FGF), in particular, a composition for breast augmentation is provided. A composition for breast augmentation that includes the above-described composition promoting an increase in subcutaneous tissue that further contains fat is provided. Specifically, a composition for breast augmentation that includes the above-described composition promoting an increase in subcutaneous tissue, wherein the fat is in the form of a lipid emulsion and the lipid emulsion is an oil-in-water lipid emulsion produced by emulsifying fat and oil in the presence of an emulsifier, and a method for breast augmentation by using the composition are provided. An injection unit of the composition for breast augmentation is also provided.

The invention discloses an natural rare bird feed addictive, which comprises the following raw materials by weight: 22-28 parts of anise powder, 22-28 parts of small fennel powder, 22-28 parts of pepper powder, 22-28 parts of clove powder, 8-11 parts of garlic powder, 22-28 parts of chili powder, 4-5 parts of honey, 22-28 parts of tea leaves powder, 22-28 parts of onion lyophilized powder, 8-11 parts of lotus leaf powder, 8-11 parts of canna root lyophilized powder, 8-11 parts of black bean powder, 2-4 parts of bitter gourd powder, 2-4 parts of elm leaf powder and 2-4 parts of Trichosanthes bark powder. According to the invention, the above raw materials are uniformly mixed to obtain the product. The addictive is added in the natural rare birds feed with the proportion of 1-2% for feeding the rare birds, the rare birds of an age of 50 days are fed by the feed with the addictive provided by the invention every day, thereby the fertility rate, survival rate and feed / egg ratio can be increased. According to the addictive of the invention, meat quality having special fragrance is formed during the growth process of the rare birds fed with the feed with the addictive, and the delicate fragrance after killing the rare birds can be still kept. Simultaneously, the subcutaneous fatty tissue of the rare birds can be obviously reduced, the meat quality can be enhanced, the dung of the rare birds has no stink, the morbidity is low, and the addictive provided by the invention is especially be beneficial to purifying environment of large-scale rare bird fields.

The invention discloses a pure natural rare poultry feed additive, which is prepared from the following raw material components in parts by weight: anise powder 22-28, cumin powder 22-28, prickly ash powder 22-28, clove powder 22-28, Garlic powder 8-11, chili powder 22-28, honey 4-5, also contains sea buckthorn powder 22-28, onion freeze-dried powder 22-28, lotus leaf powder 8-11, canna root freeze-dried powder 8-11, black beans Powder 8-11, Bitter Melon Powder 2-4, Pumpkin Powder 2-4, Carrot Powder 2-4, Trichosanthes Peel Powder 2-4. After mixing the above raw materials evenly, it is ready. Add it to rare poultry feed at a ratio of 1-2%, and feed 50-day-old rare poultry with the feed of the present invention every day, so that it can form meat with a unique fragrance during the growth process, and the fragrance will not decrease after slaughter. , significantly reduces the subcutaneous fat tissue, improves the meat quality, and the excrement of rare poultry has no odor, which is especially beneficial to the environmental purification of large-scale rare poultry farms.

The invention provides an automatic intra-abdominal muscle and fat image segmentation method, which is used for simultaneously segmenting abdominal muscle tissues, visceral fat tissues and subcutaneous fat tissues. The method mainly comprises the following steps of: classifying pixels of an abdominal image to obtain a preliminary pixel value change range of fat tissues, muscle tissues and a background part; Secondly, performing further segmentation on the basis of the pixel value change range of the muscle tissue to obtain an outer contour part and an inner contour part of the muscle respectively, and finishing the segmentation of the muscle tissue based on the parts. Finally, the adipose tissue segmented in the first step is divided into two parts by the muscle tissue, and the visceral adipose tissue is located in the muscle tissue. The subcutaneous adipose tissue is located outside the muscle tissue. Compared with the prior art, the method has the advantages that all sliced musculartissues and adipose tissues are segmented at a time, the correct rate is high, and full-automatic segmentation is achieved.

The invention relates to nutritional compositions comprising specifically designed lipid globules that are especially suited for preterm infants, small for gestational age infants and infants with retarded growth due to physical or mental stress after birth, for promoting catch-up growth and / or for use in improving body composition, improving adipose tissue distribution, decreasing visceral adipose tissue based on body weight and / or on total adipose tissue, and / or decreasing the ratio visceral adipose tissue to subcutaneous adipose tissue, in such infants, and / or providing nutrition to such infants.

Embodiments of the present disclosure are directed to methods of inducing therapeutic adipose tissue inflammation using high frequency pressure waves (e.g. high frequency shockwaves) wherein the inflammation results in a reduction in the volume of subcutaneous adipose tissue. Embodiments include applying electrohydraulic generated shockwaves at a rate of between 10 Hz and 100 Hz to reduce the appearance of cellulite or the volume of subcutaneous fat in a treatment area.

The invention relates to nutritional compositions comprising specifically designed lipid globules that are especially suited for preterm infants, small for gestational age infants and infants with retarded growth due to physical or mental stress after birth, for promoting catch-up growth and / or for use in improving body composition, improving adipose tissue distribution, decreasing visceral adipose tissue based on body weight and / or on total adipose tissue, and / or decreasing the ratio visceral adipose tissue to subcutaneous adipose tissue, in such infants, and / or providing nutrition to such infants.